Slideshow
Author(s):
Is there a connection between this patient’s ocular symptoms and migraines?
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Electronic Health Record Study Finds No Significant Cardiovascular Risk With Triptan Use for Migraine
Special Episode: Breaking Down the FDA’s Latest Migraine Therapy Approvals with Stewart Tepper, MD
FDA Approves Fremanezumab as First Anti-CGRP Preventive Therapy for Pediatric Episodic Migraine
Sleeping Around the Podcast × NeurologyLive: Erenumab, Migraine, and Sleep
NeurologyLive® Friday 5 — July 25, 2025
Exploring Use of AI Tools for Cardiovascular Risk Prediction in Migraine: Chia-Chun Chiang, MD